MARÍA NÚÑEZ NÚÑEZ-rekin lankidetzan egindako argitalpenak (12)

2024

  1. National Survey and consensus document on dosing strategies for beta-lactam antibiotics against multidrug-resistant gram-negative bacilli (MDR-GNB) in critically ill patients undergoing extracorporeal life support techniques: The DOSEBL study protocol

    Farmacia Hospitalaria

  2. Post-publication research integrity concerns in randomized clinical trials: A scoping review of the literature

    International Journal of Gynecology and Obstetrics, Vol. 166, Núm. 3, pp. 984-993

2023

  1. Assessing the Integrity of Clinical Trials Included in Evidence Syntheses

    International Journal of Environmental Research and Public Health, Vol. 20, Núm. 12

  2. International multi-stakeholder consensus statement on clinical trial integrity

    BJOG: An International Journal of Obstetrics and Gynaecology, Vol. 130, Núm. 9, pp. 1096-1111

  3. Research integrity in randomized clinical trials: A scoping umbrella review

    International Journal of Gynecology and Obstetrics, Vol. 162, Núm. 3, pp. 860-876

2022

  1. Identification of IL-6 Signalling Components as Predictors of Severity and Outcome in COVID-19

    Frontiers in Immunology, Vol. 13

  2. Research integrity in clinical trials: innocent errors and spin versus scientific misconduct

    Current Opinion in Obstetrics and Gynecology, Vol. 34, Núm. 5, pp. 332-339

  3. Second Victim Support at the Core of Severe Adverse Event Investigation

    International journal of environmental research and public health, Vol. 19, Núm. 24

2021

  1. Glucocorticoids alone versus tocilizumab alone or glucocorticoids plus tocilizumab in patients with severe SARS-CoV-2 pneumonia and mild inflammation

    Medicina Clinica, Vol. 156, Núm. 12, pp. 602-605

2020

  1. Dalbavancin is a novel antimicrobial against Gram-positive pathogens: Clinical experience beyond labelled indications

    European Journal of Hospital Pharmacy, Vol. 27, Núm. 5, pp. 310-312

  2. Randomized, double-blind, controlled trial, phase III, to evaluate the use of platelet-rich plasma versus hyaluronic acid in hip coxarthrosis

    Revista Espanola de Cirugia Ortopedica y Traumatologia, Vol. 64, Núm. 2, pp. 134-142

  3. Uso de dalbavancina en pacientes en hemodiálisis con infecciones protésicas endovasculares por microorganismos multirresistente.

    Diálisis y trasplante: publicación oficial de la Sociedad Española de Diálisis y Trasplante, Vol. 41, Núm. 2, pp. 18-20